|
1
|
Pan X, Zhang X, Sun H, Zhang J, Yan M and
Zhang H: Autophagy inhibition promotes 5-fluorouraci-induced
apoptosis by stimulating ROS formation in human non-small cell lung
cancer A549 cells. PLoS One. 8:e566792013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chiu LY, Hu ME, Yang TY, Hsin IL, Ko JL,
Tsai KJ and Sheu GT: Immunomodulatory protein from Ganoderma
microsporum induces pro-death autophagy through Akt-mTOR-p70S6K
pathway inhibition in multidrug resistant lung cancer cells. PLoS
One. 10:e01257742015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsin IL, Sheu GT, Jan MS, Sun HL, Wu TC,
Chiu LY, Lue KH and Ko JL: Inhibition of lysosome degradation on
autophagosome formation and responses to GMI, an immunomodulatory
protein from Ganoderma microsporum. Br J Pharmacol. 167:1287–1300.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsin IL, Ou CC, Wu TC, Jan MS, Wu MF, Chiu
LY, Lue KH and Ko JL: GMI, an immunomodulatory protein from
Ganoderma microsporum, induces autophagy in non-small cell lung
cancer cells. Autophagy. 7:873–882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu L, Pickle LW, Ghosh K, Naishadham D,
Portier K, Chen HS, Kim HJ, Zou Z, Cucinelli J, Kohler B, et al:
Predicting US- and state-level cancer counts for the current
calendar year: Part II: Evaluation of spatiotemporal projection
methods for incidence. Cancer. 118:1100–1109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen HS, Portier K, Ghosh K, Naishadham D,
Kim HJ, Zhu L, Pickle LW, Krapcho M, Scoppa S, Jemal A, et al:
Predicting US- and state-level cancer counts for the current
calendar year: Part I: Evaluation of temporal projection methods
for mortality. Cancer. 118:1091–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seifi-Najmi M, Hajivalili M, Safaralizadeh
R, Sadreddini S, Esmaeili S, Razavi R, Ahmadi M, Mikaeili H,
Baradaran B, Shams-Asenjan K, et al: SiRNA/DOX lodeded chitosan
based nanoparticles: Development, characterization and in vitro
evaluation on A549 lung cancer cell line. Cell Mol Biol. 62:87–94.
2016.PubMed/NCBI
|
|
8
|
Li J, Yi W, Jiang P, Sun R and Li T:
Effects of ambroxol hydrochloride on concentrations of paclitaxel
and carboplatin in lung cancer patients at different administration
times. Cell Mol Biol. 62:85–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rajewsky N: microRNA target predictions in
animals. Nat Genet. 38 Suppl 38:S8–S13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosa A and Brivanlou AH: MicroRNAs in
early vertebrate development. Cell Cycle. 8:3513–3520. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harfe BD: MicroRNAs in vertebrate
development. Curr Opin Genet Dev. 15:410–415. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fattore L, Costantini S, Malpicci D,
Ruggiero CF, Ascierto PA, Croce CM, Mancini R and Ciliberto G:
MicroRNAs in melanoma development and resistance to target therapy.
Oncotarget. 8:22262–22278. 2017.PubMed/NCBI
|
|
15
|
Lin X, Khalid S, Qureshi MZ, Attar R,
Yaylim I, Ucak I, Yaqub A, Fayyaz S, Farooqi AA and Ismail M: VEGF
mediated signaling in oral cancer. Cell Mol Biol. 62:64–68. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Chen J, Dai J, Zhang B, Wang F and
Sun Y: MicroRNA-16-1 inhibits tumor cell proliferation and induces
apoptosis in A549 non-small cell lung carcinoma cells. Oncol Res.
24:345–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu Y, Wang XD, Lu JJ, Lei YY, Zou JY and
Luo HH: Effect of mir-16 on proliferation and apoptosis in human
A549 lung adenocarcinoma cells. Int J Clin Exp Med. 8:3227–3233.
2015.PubMed/NCBI
|
|
18
|
Fan L, Qi H, Teng J, Su B, Chen H, Wang C
and Xia Q: Identification of serum miRNAs by nano-quantum dots
microarray as diagnostic biomarkers for early detection of
non-small cell lung cancer. Tumour Biol. 37:7777–7784. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bandi N, Zbinden S, Gugger M, Arnold M,
Kocher V, Hasan L, Kappeler A, Brunner T and Vassella E: miR-15a
and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Navarro A, Diaz T, Gallardo E, Viñolas N,
Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas
J, et al: Prognostic implications of miR-16 expression levels in
resected non-small-cell lung cancer. J Surg Oncol. 103:411–415.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ke Y, Zhao W, Xiong J and Cao R:
Downregulation of miR-16 promotes growth and motility by targeting
HDGF in non-small cell lung cancer cells. FEBS Lett. 587:3153–3157.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang N, Wu J, Qiu W, Lyu Q, He J, Xie W,
Xu N and Zhang Y: MiR-15a and miR-16 induce autophagy and enhance
chemosensitivity of camptothecin. Cancer Biol Ther. 16:941–948.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee DE, Brown JL, Rosa ME, Brown LA, Perry
RA Jr, Wiggs MP, Nilsson MI, Crouse SF, Fluckey JD, Washington TA,
et al: microRNA-16 is downregulated during insulin resistance and
controls skeletal muscle protein accretion. J Cell Biochem.
117:1775–1787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng YE, Yao XH, Yan ZP, Liu JX and Liu
XH: Potential signaling pathway involved in
sphingosine-1-phosphate-induced epithelial-mesenchymal transition
in cancer. Oncol Lett. 12:379–382. 2016.PubMed/NCBI
|
|
25
|
Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang
Y, Feng T, Wu J and Liu X: Sphingosine-1-phosphate induced
epithelial- mesenchymal transition of hepatocellular carcinoma via
an MMP-7/syndecan-1/TGF-β autocrine loop. Oncotarget.
7:63324–63337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zou M, Wang F, Gao R, Wu J, Ou Y, Chen X,
Wang T, Zhou X, Zhu W, Li P, et al: Autophagy inhibition of
hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced
fibrogenesis in human cardiac fibroblasts. Sci Rep. 6:247472016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo
Y, Song Z, Zheng Q and Xiong J: Autophagy promotes hepatocellular
carcinoma cell invasion through activation of
epithelial-mesenchymal transition. Carcinogenesis. 34:1343–1351.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee JG and Wu R: Combination
erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib
resistant lung cancer. PLoS One. 7:e485322012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo JY and White E: Autophagy, metabolism,
and cancer. Cold Spring Harb Symp Quant Biol. 81:73–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chakrabarti M, Klionsky DJ and Ray SK:
miR-30e blocks autophagy and acts synergistically with
proanthocyanidin for inhibition of AVEN and BIRC6 to increase
apoptosis in glioblastoma stem cells and glioblastoma SNB19 cells.
PLoS One. 11:e01585372016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu FL, Mo EP, Yang L, Du J, Wang HS,
Zhang H, Kurihara H, Xu J and Cai SH: Autophagy is involved in
TGF-β1-induced protective mechanisms and formation of
cancer-associated fibroblasts phenotype in tumor microenvironment.
Oncotarget. 7:4122–4141. 2016. View Article : Google Scholar : PubMed/NCBI
|
